prescribed to
hospital
BIOPRODUCTION SITES in the world
of LFB’s biomedicinal products are intended for the treatment of patients with rare diseases
in 2022.
IN THE FIELD OF PLASMA-DERIVED MEDICINAL PRODUCTS
5:31
Interview with Jacques Brom, June 2023
1:43
"The Powers of Blood" series: épisode 2 “What is Plasma?"
4:17
November 2022: new LFB Arras plant
5:01
The fractionation of the LFB plasma-derived medicinal products : 1 plant on 2 sites
